TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Primary human cells for Organ-on-chip studies

Laboratory reagents
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency: "Primary human cells for Organ-on-chip studies". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthoritySecretary of State for Health and Social Care acting as part of the Crown through UK Health Security AgencyScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
1.5Bids / Report
72.7% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 125 active published awards; 77 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published24 Jul 2024, 16:03 BST
Last source update24 Jul 2024, 16:03 BST
Recurring procurementNot published
ClassificationLaboratory reagents
Delivery area
UK
OCIDocds-h6vhtk-048446
What is being bought
This VEAT notice indicates that the UK Health Security Agency (UKHSA) intends to directly award a contract to Lonza Group UK Ltd for the purchase of HLA-typed human small airway epithelial cells (SAEC), lung microvascular endothelial cells (HMVEC-L), and human immune cells (PBMC) over a three-year period.
What changed
From the official release history
  1. Status changed to complete
    24 Jul 2024, 16:03 BST
  2. Official notice release published
    24 Jul 2024, 16:03 BST
  3. Buyer information updated
    24 Jul 2024, 16:03 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    Status not published
    Published valueNot published
    UKHSA requires to purchase HLA typed matching human small airway epithelial cells (SAEC), lung microvascular endothelial cells (HMVEC-L) and human immune cells (PMBC) over a 3-year period. Cells will be used in an established human Lung on a Chip (LoC) system at Porton Down. In order that LoC platforms can generate the most representative models of human organs, cells harvested directly from recently deceased, healthy humans are required (primary human cells). UKHSA believes that the only supplier that has a large enough clinical network underpinning their catalogue to maximise availability of donors to UKHSA (and the critical donor information including HLA type) is Lonza Group. Supply of these specific cells are limited. While suppliers/re-sellers of some cell types could be found, the requirement for having SAEC and MVEC from the same donor along with a large bank of Peripheral blood mononuclear cells (PBMC) donors in order to maximise compatibility excluded the majority of the small operations and re-sellers. Therefore, a decision has been made to enter into a 3-year agreement with Lonza Group for this procurement with 12-month extension option available.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    24 Jul 2024, 16:03 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 4 Jul 2024, 00:00 BST · Not published
Commercial outcome and competition
Awards
Awarded supplier not published
Not published · Not published · active
Contracts
Contract
Not published · signed 4 Jul 2024, 00:00 BST · active
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

Contracting authority GB-FTS-91907
View buyer profile
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleCompetition is absent for technical reasons.